Skip to content

Determining the Potential Benefit of Powered Prostheses

Determining the Potential Benefit of Powered Prostheses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02828982
Enrollment
12
Registered
2016-07-12
Start date
2016-07-31
Completion date
2019-08-31
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Traumatic, Unilateral Traumatic Amputation

Keywords

powered ankle prosthesis, activity monitoring, muscle fatigue, below knee amputation

Brief summary

The goal of this research is to determine the effectiveness of a powered prosthesis compared to an unpowered prosthesis during short bouts of walking, extended periods of walking (to fatigue), and performance in the community.

Detailed description

Many individuals are living in the United States with limb loss. With the use of a prosthetic device many individuals can stay active, but most do not achieve a medically desired physical activity level. This creates a risk for cardiovascular disease. It is thought that individuals with amputation walk less because it is more difficult to get around, and recent advances in robotic prosthetic technology may make such activities easier. However, these prostheses have not yet been evaluated to determine their effectiveness during extended periods of walking. Despite the goals in design of new devices it is unclear whether individuals using them are able to incorporate them into making daily activities easier. Therefore, the goal of this research is to determine the effectiveness of a powered prosthesis compared to an unpowered prosthesis during long periods of walking.

Interventions

This device is a commercially available powered ankle prosthesis, (BioM, Bionx, Bedford, MA) which was given FDA device exempt status.

DEVICEDynamic Response Foot

This condition is a sham condition as the participant will wear the prosthesis they were clinically prescribed and usually wear.

Sponsors

Deanna H Gates
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (over 21 years old), Has unilateral transtibial amputation, has used prosthesis for at least 6 months, is currently using an unpowered prosthesis, can walk unassisted for at least 10 minutes

Exclusion criteria

* History of orthopedic or neurologic disorders to their intact limb, history of cardiovascular disease that prevents them from safely completing requested activities, unable to walk for 30 minutes at a time

Design outcomes

Primary

MeasureTime frameDescription
Metabolic Cost of WalkingTesting took place after wearing the prostheses for two weeksMetabolic costs will be measured using a portable metabolic system when participants walk on a treadmill at a fixed speed.
Total Steps Outside the Home Over a Two Week Period2 weeksActivity data we be collected using activity monitors and GPS with both the regular prosthesis and the powered ankle prosthesis. Each activity monitoring period will last 2 weeks and will be done within in a 2 month period. Daily step count taken outside of the home, determined using an activity monitor and GPS device
Quality of Life (QoL) on a Short-Form 36Questionnaire completed 2 weeks after wearing each prosthesisParticipants completed the Medical Outcomes Study 36 Items Short-Form Health Survey (SF-36) after each condition. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

Secondary

MeasureTime frameDescription
Prosthetic Evaluation Questionnaire (PEQ)Questionnaire completed 2 weeks after wearing each prosthesisParticipants completed a survey to evaluate their prosthetic satisfaction (Prosthetic Evaluation Questionnaire) after each condition. Most questions in the PEQ use a visual analog scale format. Each visual analog scale is scored as a continuous numerical variable measured as the distance in millimeters from the left endpoint of the line (0 mm) to the point at which the respondent's mark crosses the line (up to 100 mm). The questions are all worded so that a higher number (toward the right) will correspond with a more positive response. Ambulation - Greater number = increased perceived ambulation Appearance - Greater number = better appearance Frustration - Greater number = less frustration Perceived Response - Greater number = increased perceived response Residual Limb Health - Greater number = better residual limb health Social burden - Greater number = less social burden Sounds - Greater number = less sound Utility - Greater
Muscle Activity in the Lower LimbTesting took place after the participant wore the prosthesis for 2 weeksParticipants walk on a treadmill while muscle activity from various lower limb muscles are monitored using electromyography. We calculated the integrated EMG (iEMG) for each muscle collected as the total activity in that muscle as a percentage of the maximum signal.
Time to FatigueTesting took place after wearing the prostheses for two weeksParticipants walk on a treadmill at a fast speed until they felt they can no longer continue. The time to fatigue was recorded.

Countries

United States

Participant flow

Recruitment details

Recruitment began after initial approval from the University of Michigan IRB (July 2016). Participants were recruited through the University of Michigan Orthotics and Prosthetics Clinic by a study physician and study prosthetist in-person, through phone or email, or with flyers.

Pre-assignment details

Participants were asked to complete both arms of the study. Before starting, participants were randomly enrolled in the dynamic response foot (unpowered prosthesis) or powered condition to start with. Some participants completed both arms while others only finished one of the arms.

Participants by arm

ArmCount
All Study Participants
This group represents all participants enrolled in the study.
12
Total12

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (3 Weeks)Withdrawal by Subject11

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous50.27 years
STANDARD_DEVIATION 13.21
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
8 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 12
other
Total, other adverse events
0 / 120 / 12
serious
Total, serious adverse events
0 / 120 / 12

Outcome results

Primary

Metabolic Cost of Walking

Metabolic costs will be measured using a portable metabolic system when participants walk on a treadmill at a fixed speed.

Time frame: Testing took place after wearing the prostheses for two weeks

Population: Each participant wore both study prostheses. One participant was excluded from analysis as he was not able to reach steady-state energetics on a treadmill

ArmMeasureValue (MEAN)Dispersion
Unpowered ProsthesisMetabolic Cost of Walking0.409 J/NmStandard Deviation 0.04
BiOM Powered ProsthesisMetabolic Cost of Walking0.397 J/NmStandard Deviation 0.078
Comparison: The null hypothesis was that there would be no difference in metabolic costs between the two groupsp-value: 0.585t-test, 2 sided
Primary

Quality of Life (QoL) on a Short-Form 36

Participants completed the Medical Outcomes Study 36 Items Short-Form Health Survey (SF-36) after each condition. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

Time frame: Questionnaire completed 2 weeks after wearing each prosthesis

Population: Each participant in the study wore both prostheses

ArmMeasureGroupValue (MEAN)Dispersion
Unpowered ProsthesisQuality of Life (QoL) on a Short-Form 36Physical Component Score62.9 scores on a scaleStandard Deviation 17.5
Unpowered ProsthesisQuality of Life (QoL) on a Short-Form 36Mental Component Score63.6 scores on a scaleStandard Deviation 19.1
BiOM Powered ProsthesisQuality of Life (QoL) on a Short-Form 36Physical Component Score59.4 scores on a scaleStandard Deviation 22
BiOM Powered ProsthesisQuality of Life (QoL) on a Short-Form 36Mental Component Score67.4 scores on a scaleStandard Deviation 24
p-value: 0.48t-test, 2 sided
Comparison: Mental Component Scorep-value: 0.408t-test, 2 sided
Primary

Total Steps Outside the Home Over a Two Week Period

Activity data we be collected using activity monitors and GPS with both the regular prosthesis and the powered ankle prosthesis. Each activity monitoring period will last 2 weeks and will be done within in a 2 month period. Daily step count taken outside of the home, determined using an activity monitor and GPS device

Time frame: 2 weeks

Population: Each participant in the study wore both prostheses

ArmMeasureValue (MEAN)Dispersion
Unpowered ProsthesisTotal Steps Outside the Home Over a Two Week Period2030 stepsStandard Deviation 1440
BiOM Powered ProsthesisTotal Steps Outside the Home Over a Two Week Period1640 stepsStandard Deviation 1100
Comparison: The null hypothesis was that there were no differences in the number of steps taken outside of the home for the two prostheses.p-value: 0.452t-test, 2 sided
Secondary

Muscle Activity in the Lower Limb

Participants walk on a treadmill while muscle activity from various lower limb muscles are monitored using electromyography. We calculated the integrated EMG (iEMG) for each muscle collected as the total activity in that muscle as a percentage of the maximum signal.

Time frame: Testing took place after the participant wore the prosthesis for 2 weeks

Population: Each participant wore both study prostheses

ArmMeasureGroupValue (MEAN)Dispersion
Unpowered ProsthesisMuscle Activity in the Lower LimbIntact side rectus femoris25.3 percentage of maximum signalStandard Deviation 4.06
Unpowered ProsthesisMuscle Activity in the Lower LimbIntact side tibialis anterior28.4 percentage of maximum signalStandard Deviation 10.2
Unpowered ProsthesisMuscle Activity in the Lower LimbIntact side biceps femoris24.3 percentage of maximum signalStandard Deviation 5.07
Unpowered ProsthesisMuscle Activity in the Lower LimbResidual side biceps femoris27.8 percentage of maximum signalStandard Deviation 10.8
Unpowered ProsthesisMuscle Activity in the Lower LimbIntact side soleus29.9 percentage of maximum signalStandard Deviation 6.47
Unpowered ProsthesisMuscle Activity in the Lower LimbResidual side rectus femoris38.3 percentage of maximum signalStandard Deviation 12.2
BiOM Powered ProsthesisMuscle Activity in the Lower LimbResidual side rectus femoris41.3 percentage of maximum signalStandard Deviation 9.01
BiOM Powered ProsthesisMuscle Activity in the Lower LimbIntact side biceps femoris24.1 percentage of maximum signalStandard Deviation 8.83
BiOM Powered ProsthesisMuscle Activity in the Lower LimbIntact side rectus femoris28.7 percentage of maximum signalStandard Deviation 14.1
BiOM Powered ProsthesisMuscle Activity in the Lower LimbIntact side soleus28.6 percentage of maximum signalStandard Deviation 9.11
BiOM Powered ProsthesisMuscle Activity in the Lower LimbIntact side tibialis anterior30.4 percentage of maximum signalStandard Deviation 7.99
BiOM Powered ProsthesisMuscle Activity in the Lower LimbResidual side biceps femoris25.9 percentage of maximum signalStandard Deviation 8.7
Comparison: Intact Side Soleusp-value: 0.844t-test, 2 sided
Comparison: Intact Side Biceps Femorisp-value: 0.655t-test, 2 sided
Comparison: Intact Side Rectus Femorisp-value: 0.281t-test, 2 sided
Comparison: Intact Side Tibialis Anteriorp-value: 0.11t-test, 2 sided
Comparison: Residual Side Biceps Femorisp-value: 0.394t-test, 2 sided
Comparison: Residual Side Rectus Femorisp-value: 0.141t-test, 2 sided
Secondary

Prosthetic Evaluation Questionnaire (PEQ)

Participants completed a survey to evaluate their prosthetic satisfaction (Prosthetic Evaluation Questionnaire) after each condition. Most questions in the PEQ use a visual analog scale format. Each visual analog scale is scored as a continuous numerical variable measured as the distance in millimeters from the left endpoint of the line (0 mm) to the point at which the respondent's mark crosses the line (up to 100 mm). The questions are all worded so that a higher number (toward the right) will correspond with a more positive response. Ambulation - Greater number = increased perceived ambulation Appearance - Greater number = better appearance Frustration - Greater number = less frustration Perceived Response - Greater number = increased perceived response Residual Limb Health - Greater number = better residual limb health Social burden - Greater number = less social burden Sounds - Greater number = less sound Utility - Greater

Time frame: Questionnaire completed 2 weeks after wearing each prosthesis

Population: Each participant wore both study prostheses.

ArmMeasureGroupValue (MEAN)Dispersion
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Frustration66.8 scores on a scaleStandard Deviation 29.7
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Social Burden85.2 scores on a scaleStandard Deviation 19.5
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Appearance85.6 scores on a scaleStandard Deviation 9.58
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Sounds71.4 scores on a scaleStandard Deviation 27.1
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Perceived Response87.6 scores on a scaleStandard Deviation 20.7
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Utility73.1 scores on a scaleStandard Deviation 14.8
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Residual Limb Health73.6 scores on a scaleStandard Deviation 19.4
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Well-Being72.9 scores on a scaleStandard Deviation 26.9
Unpowered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Ambulation75.2 scores on a scaleStandard Deviation 18.3
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Well-Being79.2 scores on a scaleStandard Deviation 22
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Ambulation84.0 scores on a scaleStandard Deviation 15.8
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Appearance80.6 scores on a scaleStandard Deviation 12.8
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Frustration84.8 scores on a scaleStandard Deviation 27.8
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Perceived Response97.1 scores on a scaleStandard Deviation 4.33
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Residual Limb Health79.9 scores on a scaleStandard Deviation 14.3
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Social Burden91.6 scores on a scaleStandard Deviation 15.3
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Sounds57.2 scores on a scaleStandard Deviation 31.5
BiOM Powered ProsthesisProsthetic Evaluation Questionnaire (PEQ)Utility74.4 scores on a scaleStandard Deviation 16.7
Comparison: Ambulation Scorep-value: 0.058t-test, 2 sided
Comparison: Appearance Scorep-value: 0.123t-test, 2 sided
Comparison: Frustration Scorep-value: 0.052t-test, 2 sided
Comparison: Perceived Response Scorep-value: 0.188t-test, 2 sided
Comparison: Residual Limb Health Scorep-value: 0.336t-test, 2 sided
Comparison: Social Burden Scorep-value: 0.043t-test, 2 sided
Comparison: Sounds Scorep-value: 0.391t-test, 2 sided
Comparison: Utility Scorep-value: 0.799t-test, 2 sided
Comparison: Well-Beingp-value: 0.173t-test, 2 sided
Secondary

Time to Fatigue

Participants walk on a treadmill at a fast speed until they felt they can no longer continue. The time to fatigue was recorded.

Time frame: Testing took place after wearing the prostheses for two weeks

Population: Each participant wore both study prostheses

ArmMeasureValue (MEAN)Dispersion
Unpowered ProsthesisTime to Fatigue14.7 minutesStandard Deviation 12.1
BiOM Powered ProsthesisTime to Fatigue13.2 minutesStandard Deviation 10.8
p-value: 0.212t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026